Mutation assays involving blood cells that metabolize toxic substances
AssigneeMassachusetts Institute of Technology
InventorsCharles L. Crespi, William G. Thilly
Life of this patent
Estimating the term…
Abstract
A line of human blood cells which have high levels of oxidative activity (such as oxygenase, oxidase, peroxidase, and hydroxylase activity) is disclosed. Such cells grow in suspension culture, and are useful to determine the mutagenicity of xenobiotic substances that are metabolized into toxic or mutagenic substances. Mutation assays using these cells, and other cells with similar characteristics, are also disclosed.
Claims6
A method for determining mutagenicity of a substance, comprising the steps of:
- a. exposing a culture of AHH-1 cells to the substance;
- b. thereafter growing the exposed AHH-1 cells for a phenotypic stabilization period;
- c. detecting the amount of mutant cells;
- and
- d. comparing the frequency of mutation of the exposed AHH-1 cells to the frequency of mutation of unexposed AHH-1 cells to determine the mutagenicity of the substance.
A method of determining the mutagenicity of a substance, comprising the steps of:
- a. dividing a culture of AHH-1 cells into at least two aliquots;
- b. exposing at least one of the aliquots to the substance;
- c. culturing the exposed aliquot and at least one unexposed aliquot for a phenotypic stabilization period;
- and
- d. comparing the frequency of mutation between the exposed and unexposed aliquots to determine the mutagenicity of the substance.
A culture consisting essentially of the human cell line AHH-1, ATCC accession number CRL 8146.
Dependencies are inferred from the claim text.